<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03912792</url>
  </required_header>
  <id_info>
    <org_study_id>DMX101-0001</org_study_id>
    <nct_id>NCT03912792</nct_id>
  </id_info>
  <brief_title>A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHED</brief_title>
  <official_title>A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by X-Linked Hypohidrotic XLHED Ectodermal Dysplasia (XLHED)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dermelix Biotherapeutics, LLC.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dermelix Biotherapeutics, LLC.</source>
  <brief_summary>
    <textblock>
      The proposed natural history study will enroll male patients with a diagnosis of XLHED,
      female carriers of XLHED and healthy volunteers. The study protocol will include collection
      of XLHED questionnaires and clinical outcomes using minimally invasive technologies. Data
      will be collected both retrospectively and prospectively.

      Clinical outcome assessments will be performed at the NFED Family Conference on July 11-12,
      2019. Study participants will be able to complete XLHED questionnaires electronically ahead
      of the conference.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Company decision
  </why_stopped>
  <start_date type="Actual">June 28, 2019</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The volume of sweat from a pilocarpine-induced sweat test</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>XLHED</condition>
  <arm_group>
    <arm_group_label>XLHED Patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Males with XLHED and female carriers of XLHED

        Male and female healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed Consent

          -  Males with XLHED, female carriers of XLHED and healthy volunteers

        Exclusion Criteria:

          -  Treatment with an investigational study drug for XLHED

          -  Any major medical problems that would prevent her/him from participating in this study

          -  Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists
             (Examples: Urecholine, Salagen, Pilocar, and Provocholine)

          -  Pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorothy K Grange, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chicago Marriott Lincolnshire Resort</name>
      <address>
        <city>Lincolnshire</city>
        <state>Illinois</state>
        <zip>60069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2019</study_first_posted>
  <last_update_submitted>June 28, 2019</last_update_submitted>
  <last_update_submitted_qc>June 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Natural History Study</keyword>
  <keyword>X-Linked Hypohidrotic Ectodermal Dysplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ectodermal Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

